Platelet Dysfunction after Coronary Artery Bypass Surgery

  • K. H. Teoh
  • Richard D. Weisel
  • J. Ivanov
  • S. J. Teasdale
  • M. F. X. Glynn

Summary

Cardiopulmonary bypass induces platelet activation and dysfunction, resulting in platelet deposition and depletion. Reduced platelet numbers and abnormal function may contribute to postoperative bleeding. In addition, myocardial deposition of activated platelets may contribute to perioperative ischemic injury and early postoperative bypass graft occlusion. Dipyridamole (DIP) reduces platelet activation and may decrease postoperative bleeding, myocardial platelet depostion and perioperative ischemic injury.

Keywords

Ischemia Aspirin Adenosine Catalase Cardiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harker LA, Malpass TW, Bronson HE, Hessel EA II, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective-granule release. Blood 56: 824–834PubMedGoogle Scholar
  2. 2.
    Addonizio VP Jr, Smith JB, Strauss JF III, Colman RW, Edmunds LH (1980) Thromboxane systhetis and platelet secretion during cardiopulmonary bypass with a bubble oxygenator. J Thorac Cardiovasc Surg 79: 91–96PubMedGoogle Scholar
  3. 3.
    Edmunds LH, Ellison N, Colman RW, et al. (1982) Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83: 805–812PubMedGoogle Scholar
  4. 4.
    Davies GC, Sobel M, Salzman EW. (1980) Elevated plasma fibrinopeptide A and thromboxane A2 levels during cardiopulmonary bypass. Circulation 61: 808–814PubMedCrossRefGoogle Scholar
  5. 5.
    Dutton RC, Edmunds LH, Hutchinson JC, Roe BB. (1974) Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters. J Thorac Cardiovasc Surg 67: 25Google Scholar
  6. 6.
    Allerdyce DB, Yoshida SH, Ashmore RG (1980) The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator. J Thorac Cardiovasc Surg 62: 936Google Scholar
  7. 7.
    DeBoer AC, Turpie AGG, But RW, Johnston RV, Genton E (1982) Platelet release and thromboxane systhesis in symptomatic coronary artery disease. Circulation 66: 327–333CrossRefGoogle Scholar
  8. 8.
    Sobel M, Salzman EW, Davies GC et al. (1981) Circulating platelet products in unstable angina pectoris. 63: 300–306Google Scholar
  9. 9.
    Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP (1981) Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia. Direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 48: 395–402PubMedCrossRefGoogle Scholar
  10. 10.
    Baylet T, Clements J, Oshahr A (1967) Pulmonary and circulatory effects of fibrinopeptides. Circ Res 21: 469–474CrossRefGoogle Scholar
  11. 11.
    Copley AL, Haning JP, Luchini BW (1967) On the capillary permeability enchancing activity of isolated fibrionopeptides and their role in the physiology of the blood capillary wall. Bibl Anat 9: 475–477PubMedGoogle Scholar
  12. 12.
    Mehta J, Mehta P, Pepine CJ (1978) Platelet aggregation in aortic and coronary venous blood in patients with and without coronary artery disease. Role of tachycardia, stress and propanolol. Circulation 58: 881–886PubMedCrossRefGoogle Scholar
  13. 13.
    Needleman P, Kulkarni PS, Raz A (1977) Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes (1977) Science 195: 409–415PubMedCrossRefGoogle Scholar
  14. 14.
    Shimamoto T, Kobayashi M, Takahashi T, Numano F, Morooka S (1977) Myocardial infarction experimentally induced by thromboxane A2. Abstract. Circulation 56 (suppl III): 3–23Google Scholar
  15. 15.
    Feinberg H, Rosenbaum DS, Levitsky S, Silverman NA, Kohler J, Le Brenton G (1982) Platelet deposition after surgically induced myocardial ischemia: An etiologic factor for reperfusion injury. J Thorac Cardiovasc Surg 84: 815–822PubMedGoogle Scholar
  16. 16.
    Rosenbaum D, Levitsky S, Silverman N et al. (1983) Cardioplegia does not prevent reperfusion injury induced by intracoronary platelet deposition. Circulation 68 (suppl II): 102–106Google Scholar
  17. 17.
    Teoh KH, Fremes SE, Weisel RD et al. (1987) Cardiac release of prostacyclin and thromboxane A2 during coronary bypass surgery. J Thorac Cardiovasc Surg 93: 120–126PubMedGoogle Scholar
  18. 18.
    Chenoweth DE, Cooper SW, Hugh TE, Stewart RW, Blackstone EH, Kirklin JW (1981) Complement activation during CPB N Engl J Med 304: 497–503PubMedCrossRefGoogle Scholar
  19. 19.
    Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of CPB. J Thorac Cardiovasc Surg 86: 845–857PubMedGoogle Scholar
  20. 20.
    Hammerschmidt DE, Stroncek DF, Bowers TK et al. (1981) Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81: 370–377PubMedGoogle Scholar
  21. 21.
    Pfueller SI, Lischer EF (1974) Studies of the mechanisms of human platelet release reaction induced by immunologic stimuli. I. Complement-dependent and complement-independent reactions. J Immunol 112: 1201–1210PubMedGoogle Scholar
  22. 22.
    Wautier JL, Ollier-Hartmann MP, Kadera H, Cohen F, Hartmann L, Caen JP (1981) First component of complement and thrombosis. Thromb Haemost 45: 247–251PubMedGoogle Scholar
  23. 23.
    Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS (1977) Complement (C5a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 60: 260–264PubMedCrossRefGoogle Scholar
  24. 24.
    Webster RO, Hong SR, Johnston RB Jr, Henson PM (1980) Biological effects of the human complement fragments C5a and C5a (des Arg) on neutrophil function. Immunopharm 2: 201 – 219CrossRefGoogle Scholar
  25. 25.
    Fountain SW, Martin BA, Busclow CE, Cooper JD (1980) Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Circ Res 46: 175–180PubMedCrossRefGoogle Scholar
  26. 26.
    Gardner TJ, Stewart JR, Casale AS, Downey JM, Chambers DE (1983) Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery 94: 423–427PubMedGoogle Scholar
  27. 27.
    Shlafer M, Kane PF, Kirsh MM (1982) Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 83: 830–839PubMedGoogle Scholar
  28. 28.
    Stewart JR, Blackwell WH, Crute SL, Loughlin V, Greenfield LJ, Hess ML (1983) Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers. J Thorac Cardiovasc Surg 86: 262–272PubMedGoogle Scholar
  29. 29.
    Fremes, SE, Chrsitakis GT, Weisel RD, Mickle DAG, Madonik MM, Ivanov J, Harding R, Seawright SJ, Houle S, McLaughlin PR, Baird RJ (1984) A clinical trial of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg 88: 726PubMedGoogle Scholar
  30. 30.
    Teoh KH, Mickle DAG, Weisel RD, Madonik MM, Ivanov J, Hardling RD, Romaschin AD, Wilson GJ, Mullen JC (1989) The effect of lactate infusion on myocardial metabolism and ventricular function following ischemia and cardioplegia. Can J Cardiol 5: 90–116Google Scholar
  31. 31.
    Teoh KH, Christakis GT, Weisel RD, Katz AM, Tong CP, Mickleborough LL, Scully HE, Baird RJ, Goldman BS (1987) Increased risk of urgent revascularization. J Thorac Cardiovasc Surg 93: 291PubMedGoogle Scholar
  32. 32.
    Best LC, McGuire MB, Jones PBB, et al (1979) Mode of action of dipyridamole on human platelets. Thromb Res 16: 367–377PubMedCrossRefGoogle Scholar
  33. 33.
    Mills DCB, Smith JB (1971) The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3:5-cyclic monophosphate in platelets. Biochem J 121: 185–196PubMedGoogle Scholar
  34. 34.
    Emmons PR, Harrison MJG, Honour AJ, Mitchell JRA (1965) Effect of dipyridamole on human platelet behaviour. Lancet 2: 603–606PubMedCrossRefGoogle Scholar
  35. 35.
    Chesebro JH, Clements IP, Fuster V, et al (1982) A platelet-inhibitor-drug trial in coronary artery bypass operations: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein graft patency. N Engl J Med 307: 73–78PubMedCrossRefGoogle Scholar
  36. 36.
    Teoh KH, Christakis GT, Weisel RD, Mullen JC, Madonik MM, Invanov J, Henderson MJ, Warbick-Cerone A, Johnston LG, Mee AV, Wong PY, Reilly PA, Glynn MFX (1986) Prevention of myocardial platelet deposition and thromboxane release with dipyridamole. Circulation 74 (suppl III): 145–152Google Scholar
  37. 37.
    Teoh KH, Chrsitakis GT, Weisel RD, Madonik MM, Ivanov J, Warbick-Cerone A, Johnston LG, Cawthorn RH, Mullen JC, Glynn MFX, Wilson GJ, Salerno TA (1987) Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia. J Surg Res 42: 642–652PubMedCrossRefGoogle Scholar
  38. 38.
    Bachmann F, McKenna R, Cole ER, Najafi H (1975) The homostatic mechanism after openheart surgy. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 70: 76–85PubMedGoogle Scholar
  39. 39.
    Bove JR (1987) Transfusion-associated hepatitis and AIDS (1987) N Engl J Med 317: 242–246PubMedCrossRefGoogle Scholar
  40. 40.
    Kennedy RH, McGoon DC, Smith HC, Kurland LT (1985) Trends in cardiac surgery in the United States. N Engl J Med 312: 119–120CrossRefGoogle Scholar
  41. 41.
    Bick RL (1985) Hemostasis defects associated with cardiac surgery prosthetic devices and other extracorporeal circuits. Semin Throm Hemostasis 11: 249–280CrossRefGoogle Scholar
  42. 42.
    Kukuk O, Kwaan HC, Frederickson J, Wade L, Green D (1986) Increased fibrinolysis in patients undergoing cardiopulmonary bypass operations. AM J Hematol 23: 223–229CrossRefGoogle Scholar
  43. 43.
    Umlas J (1967) Fibrinolysis and disseminated intravascular coagulation in open heart surgery. Transfusion 16: 460–463CrossRefGoogle Scholar
  44. 44.
    Mayer M, Finci Z, Chaouat M (1986) Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes. J Mol Cell Cardiol 18: 1117–1124PubMedCrossRefGoogle Scholar
  45. 45.
    Gilbert JW, Bronson WR, Brecher G (1964) Incidence of bleeding in cardiac surgery with extracorporeal circulation. Ann NY Aca Sci 115: 302–304CrossRefGoogle Scholar
  46. 46.
    Tice DA, Reed GE, Clauss RH, Worth MH (1963) Hemorrhage due to fibrinolysis occurring with open heart surgery. J Thorac Cardiovasc Surg 46: 673–679PubMedGoogle Scholar
  47. 47.
    Van Oeveren W, Jansen NJG, Bistrup BP et al. (1987) Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thor Surg 44: 640–645CrossRefGoogle Scholar
  48. 48.
    Royston D, Bidstrup BP, Taylor KM, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet II: 1289–1291CrossRefGoogle Scholar
  49. 49.
    Bidstrup BP, Royston D, Taylor KM, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion in patients with septic endocarditis having open-heart surgery. Lancet I: 366–367Google Scholar
  50. 50.
    Horrow JC, Hlavacek J, Strong MD, et al (1990) Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 99: 70–74PubMedGoogle Scholar
  51. 51.
    Addonizo VP Jr, Strauss JF III, Colman RW, Edmunds LH Jr (1979) Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J Thorac Cardiovasc Surg 77: 119Google Scholar
  52. 52.
    Musial J, Niewiarowski S, Hershock D, Morinelli TA, Colman RW, Edmunds LH Jr. (1985) Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 105: 514–522PubMedGoogle Scholar
  53. 53.
    Gluszko P, Rucinski B, Musial J, et al. (1987) Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am J Physiol 252 (Heart Circ Physiol 21): H 615–621Google Scholar
  54. 54.
    Mammen EF, Koets MH, Washington BC, et al. (1985) Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 11: 281–292PubMedCrossRefGoogle Scholar
  55. 55.
    Harker LA (1986) Bleeding after cardiopulmonary bypass. N Engl J Med 314: 1446–1448PubMedCrossRefGoogle Scholar
  56. 56.
    Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS (1982) Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand’s disease subtypes. Blood 59: 1272 – 1278PubMedGoogle Scholar
  57. 57.
    Czer L, Bateman T, Gray R, et al. Prospective trial of DDAVP in treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass. Circulation 72: 130Google Scholar
  58. 58.
    Salzman E, Weinstein M, Weintraub E, et al. (1986) Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 314: 1402–1406PubMedCrossRefGoogle Scholar
  59. 59.
    Teoh KH, Christakis GT, Weisel RD, Wong PY, Ivanov J, Madonik MM, Levitt DS, Reilly PA, Rosenfeld JM, Glynn MFX (1988) Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 96: 332–341PubMedGoogle Scholar
  60. 60.
    Teoh KH, Christakis GT, Weisel RD, Madonik MM, Ivanov J, Wong PY, Mee AV, Levitt D, Benak A, Reilly PA, Glynn MFX. (1987) Blood conservation with membrane oxygenators and dipyridamole. Ann Thorac Surg 44: 40–47PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • K. H. Teoh
    • 1
  • Richard D. Weisel
    • 1
    • 2
  • J. Ivanov
    • 1
  • S. J. Teasdale
    • 1
  • M. F. X. Glynn
    • 1
  1. 1.Divisions of Cardiovascular Surgery, Cardiac Anesthesia and Hematology of the Toronto HospitalThe University of Toronto and the Center for Cardiovascular ResearchCanada
  2. 2.Cardiovascular SurgeryToronto General HospitalTorontoCanada

Personalised recommendations